Treatments for aortic disease offered at Duke include
medications as well as minimally invasive endovascular
therapies.
Medications
Antihypertensive drugs or beta blockers may help slow an
aneurysm growth or prevent complications.
Especially for patients with the Marfan syndrome,
angiotensive receptor blockers (ARBs) are showing promise in
early studies for preventing aortic dilatation.
For young patients with the Marfan syndrome (those less than
25 years of age who meet study criteria), Duke is participating
in an NIH-sponsored clinical trial examining the best medical
treatment for slowing the progression of aortic root
enlargement.
Minimally Invasive Endovascular Therapies
Duke is one of the leading implementers of thoracic stent
grafts in the United States.
More and more patients are taking advantage of these
therapies, which have replaced open surgery in many cases.
These therapies allow patients to recover faster, and they
result in less morbidity and mortality than open surgery.
Click a link for information about how endovascular
techniques are used to treat:
Physicians
Physicians offering this service include:
Locations
This service is available at:
